Drug transfer through mucus

Advanced Drug Delivery Reviews

Volumn 48, Issue 2-3, 2001, Pages 173-193

  Khanvilkar, Kavita ^a   Donovan, Maureen D ^a   Flanagan, Douglas R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Diffusion; Drug absorption; Mucin; Mucosal absorption; Mucus

Indexed keywords

DEBRIS; DIFFUSION; ENZYMES; GELS; LIPIDS; SALTS; TISSUE;

MUCUS;

DRUG PRODUCTS;

ACETYLFERROCENE; AMINOPHENAZONE; AMINOSALICYLIC ACID; ASCORBIC ACID; BENZOIC ACID; CATECHOL; CLARITHROMYCIN; CYCLOSPORIN A; DESMOPRESSIN; FERRIC SULFATE; FERROCENE CARBOXALDEHYDE; FERROCENE CARBOXYLIC ACID; FERROCENE DERIVATIVE; FERROCENE DICARBOXYLIC ACID; FERROUS CHLORIDE; FERROUS SULFATE; GLUCOSAMINE; GLUCURONIC ACID; ISONIAZID; MANNITOL; PENTAMIDINE; PHENAZONE; PHENYLALANINE; PHENYLBUTAZONE; PYRAZINAMIDE; RIFAMPICIN; TESTOSTERONE; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN;

BINDING SITE; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG BINDING; DRUG DIFFUSION; DRUG MECHANISM; DRUG PENETRATION; DRUG PROTEIN BINDING; EPITHELIUM; EXPERIMENTAL MODEL; GASTROINTESTINAL MUCOSA; HUMAN; MOUTH MUCOSA; MUCUS; NONHUMAN; NOSE MUCUS; PRIORITY JOURNAL; PROTEIN CONFORMATION; RESPIRATORY TRACT MUCOSA; REVIEW; SPECIES DIFFERENCE; VAGINA MUCOSA;

ABSORPTION; ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; MODELS, THEORETICAL; MUCUS; PHARMACOKINETICS;

EID: 0035844741     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00115-6     Document Type: Review

References (129)

1. Widdicombe J.G. Airway liquid: a barrier to drug diffusion? Eur. Respir. J. 10:1997;2194-2197.
2. Thomson A.B., Dietschy J.M. Derivation of the kinetics that describe the effects of unstirred water layers on the kinetic parameters of active transport processes in the intestine. J. Theor. Biol. 64:1977;277-294.
3. Elstein M., Fawcett G.M. Effects of the anti-oestrogens, clomiphene and tamoxifen, on the cervical factor in female infertility. Mucus and Mucosa, Ciba Foundation Symposium, Vol. 109:1984;173-179 Pitman, London.
4. Wolf D.P., Blasco L., Khan M.A., Litt M. Human cervical mucus IV. Viscoelasticity and sperm penetrability during the ovulatory menstrual cycle. Fertil. Steril. 30:1978;163-169.
5. Longer M.A., Ch'ng H.S., Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery. III. Oral delivery of chlorothiazide using a bioadhesive polymer. J. Pharm. Sci. 74:1985;406-411.
6. Nagai T., Nishimoto Y., Nambu N., Suzuki Y., Sekine K.J. Powder dosage form of insulin for nasal administration. J. Controlled Release. 1:1984;15-22.
7. Lejoyeux F., Ponchel G., Wousessidjewe D., Peppas N.A., Duchene D. Bioadhesive tabletsinfluence of the testing medium composition on bioadhesion. Drug Dev. Ind. Pharm. 15:1989;2037-2048.
8. Rathbone M.J., Hadgraft J. Absorption of drugs from the human oral cavity. Int. J. Pharm. 74:1991;9-24.
9. L. Shei, Mucin as a Biological Surfactant to Protect Biomaterial Surfaces, Ph.D. Thesis, University of Utah, 1999.
10. Creeth J.M. Constituents of mucus and their separation. Br. Med. Bull. 34:1978;17-24.
11. Roussel P., Degand P., Lamblin G., Laine A., Lafitte J.J. Biochemical definition of human tracheobronchial mucus. Lung. 154:1978;241-260.
12. Jeffery P.K. The origins of secretions in the lower respiratory tract. Eur. J. Respir. Dis. 71:(Suppl. 153):1987;34-42.
13. Reid L.M., Bhaskar K.R. Macromolecular and lipid constituents of bronchial epithelial mucus. Chantler E., Ratcliffe N.A., Mucus and Related Topics. 1989;201-219 The Company of Biologists, Cambridge.
14. Ryley H.C., Brogan T.D. Quantitative immunoelectrophoretic analysis of the plasma proteins in the sol phase of sputum from patients with chronic bronchitis. J. Clin. Pathol. 26:1973;852-856.
15. Brogan T.D., Ryley H.C., Neale L., Yassa J. Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and chronic bronchitis. Thorax. 30:1975;72-79.
16. Ryley H.C. An immunoelectrophoretic study of the soluble secretory proteins of sputum. Biochim. Biophys. Acta. 271:1972;300-309.
17. Widdicombe J.G. Role of lipids in airway function. Eur. J. Respir. Dis. 71:(Suppl. 153):1987;197-204.
18. Chernick W.S., Barbero G.J. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics. 24:1959;739-745.
19. Slomiany A., Murty V.L.N., Aono M., Snyder C.E., Herp A., Slomiany B.L. Lipid composition of tracheobronchial secretions from normal individuals and patients with cystic fibrosis. Biochim. Biophys. Acta. 710:1982;106-111.
20. Spicer S.S., Martinez J.R. Mucin biosynthesis and secretion in the respiratory tract. Environ. Health Perspect. 55:1984;193-204.
21. Butler B.D., Lichtenberger L.M., Hills B.A. Distribution of surfactants in the canine GI tract and their ability to lubricate. Am. J. Physiol. 244:1983;G645-G651.
22. Lichtenberger L.M., Graziani L.A., Dial E.J., Butler B.D., Hills B.A. Role of surface-active phospholipids in gastric cytoprotection. Science. 219:1983;1327-1329.
23. Slomiany A., Galicki N.I., Kojima K., Banas-Gruszka Z., Slomiany B.L. Glyceroglucolipids of the mucous barrier of dog stomach. Biochim. Biophys. Acta. 665:1981;88-91.
24. Slomiany A., Jozwiak Z., Takagi A., Slomiany B.L. The role of covalently bound fatty acids in the degradation of human gastric mucus glycoprotein. Arch. Biochem. Biophys. 229:1984;560-567.
25. Slomiany B.L., Kasinanthan C., Slomiany A. Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol). Am. J. Gastroenterol. 84:1989;1273-1277.
26. Slomiany B.L., Sarosiek J., Slomiany A. Gastric mucus and the mucosal barrier. Dig. Dis. 5:1987;125-145.
27. Slomiany B.L., Slomiany A. Role of mucus in gastric mucosal protection. J. Physiol. Pharmacol. 42:1991;147-161.
28. Slomiany A., Yano S., Slomiany B.L., Glass G.B.J. Lipid composition of the gastric mucous barrier in the rat. J. Biol. Chem. 253:1978;3785-3791.
29. Larhed A.W., Artursson P., Bjork E. The influence of intestinal mucus components on the diffusion of drugs. Pharm. Res. 15:1998;66-71.
30. Neutra M.R., Forstner J.F. Johnson L.R., Physiology of the Gastrointestinal Tract. 1987;975-1009 Raven, New York.
31. Filipe M.I. Mucins in the human gastrointestinal epithelium: a review. Invest. Cell Pathol. 2:1979;195-216.
32. Roussel P., Lamblin G., Lhermitte M., Houdret N., Lafitte J.J., Perini J.M., Klein A., Scharfman A.P. The complexity of mucins. Biochimie. 70:1988;1471-1482.
33. Strous G.J., Dekker J. Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol. 27:1992;57-92.
34. Pigman W., Moshera J.L. The nature and function of the epithelial mucous glycoproteins. Blandau R.J., Moghissi K., The Biology of the Cervix. 1973;143-172 University of Chicago Press, Chicago.
35. Ginsburg V., Neufeld E.F. Complex heterosaccharides of animals. Annu. Rev. Biochem. 38:1969;371-388.
36. Kornfeld R., Kornfeld S. Comparative aspects of glycoprotein structure. Annu. Rev. Biochem. 45:1976;217-237.
37. S. Roseman, Biosynthesis of glycoproteins, gallyosides and proteins, in: Fourth Intl. Conf. Cystic Fibrosis of the Pancreas (Mucoviscidosis), Part II, Karger, Basel, 1968, pp. 244-269.
38. Sharon N. Polysaccharides. Annu. Rev. Biochem. 35:1966;485-520.
39. Oates M.D., Rosbottom A.C., Schrager J. Further investigations into the structure of human gastric mucin: the structural configuration of the oligosaccharide chains. Carbohydrate Res. 34:1974;115-137.
40. Carlson D.M. Oligosaccharides isolated from pig submaxillary mucin. J. Biol. Chem. 241:1966;2984-2986.
41. Carlson D.M. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. J. Biol. Chem. 243:(3):1968;616-626.
42. Spiro R.G. Glycoproteins. Annu. Rev. Biochem. 39:1970;599-638.
43. Gibbons R.A. Polydispersity. Nature. 200:1963;665-666.
44. Gibbons R.A., Creeth J.M., Denborough M.A. Biophysical characteristics of the blood. Aminoff D., Blood and Tissue Antigens. 1970;307-324 Academic Press, New York.
45. Dekker J., Van Beurden-Lamers W.M., Oprins A., Straus G.J. Isolation and structural analysis of rat gastric mucus glycoprotein suggests a homogeneous protein backbone. Biochem. J. 260:1989;717-723.
46. Moore J.C., Tiffany J.M. Human ocular mucuschemical studies. Exp. Eye Res. 33:1981;203-212.
47. Wolf D.P., Sokoloski J., Khan M.A., Litt M. Human cervical mucus III: Isolation and characterization of rheologically active mucin. Fertil. Steril. 28:1977;53-58.
48. Tam P.Y., Verdugo P. Control of mucus hydration as a Donnan equilibrium process. Nature. 292:1981;340-342.
49. Goddard P.J., Kao Y.-C., Lichtenberger L.M. Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucus gel. Gastroenterology. 98:1990;361-370.
50. Hills B.A. Gastric surfactant and the hydrophobic mucosal barrier. Gut. 39:1996;621-624.
51. Werther J.L. The gastric mucosal barrier. Mount Sinai J. Med. 67:2000;41-53.
52. Lichtenberger L.M. The hydrophobic barrier properties of gastrointestinal mucus. Annu. Rev. Physiol. 57:1995;565-583.
53. Bansil R., Stanley E., LaMont J.T. Mucin biophysics. Annu. Rev. Physiol. 57:1995;635-657.
54. Sheehan J.K., Oates K., Carlstedt I. Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. Biochem. J. 239:1986;147-153.
55. Bhushana-Rao K.S.P., Masson P.L. A tentative model for the structure of bovine oestrus cervical mucus. Elstein M., Paske D.V., Mucus in Health and Disease I. 1977;275-282 Plenum Press, New York.
56. Carlstedt I., Sheehan J.K. Macromolecular properties and polymeric structure of mucus glycoproteins. Mucus and Mucosa, Ciba Foundation Symposium, Vol. 109:1984;157-172 Pitman, London.
57. Meyer F.A., Silberberg A. Structure and function of mucus. Respiratory Tract Mucus, Ciba Foundation Symposium, Vol. 54:1978;203-218 Elsevier, Amsterdam.
58. Allen A. Structure and function of gastrointestinal mucus. Johnson L.R., Physiology of the Gastrointestinal Tract. 1981;617-639 Raven Press, New York.
59. Verdugo P., Tam P.Y., Butler J. Conformational structure of respiratory mucus studied by laser correlation spectroscopy. Biorheology. 20:1983;223-230.
60. Cao X., Bansil R., Bhaskar K.R., Bradley S.T., LaMont J.T., Niu N., Afdhal N.H. pH-dependent conformational change of gastric mucin leads to sol-gel transition. Biophys. J. 76:1999;1250-1258.
61. Kerss S., Allen A., Garner A. A simple method for measuring the thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. Clin. Sci. 63:1982;187-195.
62. Sakata T., Engelhardt W.V. Luminal mucin in the large intestine of mice, rats and guinea pigs. Cell Tissue Res. 219:1981;629-635.
63. Rozee K.R., Cooper D., Lam K., Costerton J.W. Microbial flora of the mouse ileum mucous layer and epithelial surface. Appl. Environ. Microbiol. 43:1982;1451-1463.
64. 2 and carbenoxolone. Gastroenterology. 80:1981;770-775.
65. Allen A., Hutton D.A., Pearson J.P., Sellers L.A. Mucus glycoprotein structure, gel formation and gastrointestinal mucus function. Mucus and Mucosa, Ciba Foundation Symposium, Vol. 109:1984;137-156 Pitman, London.
66. Duchene D., Touchard F., Peppas N.A. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharm. 14:1988;283-318.
67. Ch'ng H.S., Park H., Kelly P., Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery. II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci. 74:1985;399-405.
68. Marriott C. Mucus: its structure, function and evaluation. Ganderton D., Jones T.M., Drug Delivery to the Respiratory Tract. 1987;68-76 Ellis Harwood, Chichester, UK.
69. Clarke S.W. Management of mucus hypersecretion. Eur. J. Respir. Dis. 71:(S153):1987;136-144.
70. Marom Z., Shelhamer J.H., Kaliner M. Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoprotein from human airways in vitro. J. Clin. Invest. 67:1981;1695-1702.
71. Coles S.J., Neill K.H., Reid L.M., Austen K.F., Nii Y., Corey E.J., Lewis R.A. Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. Prostaglandins. 25:1983;155-170.
72. Boat T.F., Cheng P.I., Klinger J.D., Leidtke C.M., Tandler B. Proteinases release mucin from airway goblet cells. Mucus and Mucosa, Ciba Foundation Symposium, Vol. 109:1984;72-87 Pitman, London.
73. Coles S.J., Bhaskar K.R., O'Sullivan D.D., Neill K.H., Reid L.M. Airway mucus: composition and regulation of its secretion by neuropeptides in vitro. Mucus and Mucosa, Ciba Foundation Symposium, Vol. 109:1984;40-60 Pitman, London.
74. Uddman R., Alumets J., Densert O., Halcanson R., Sundler F. Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol. 86:1978;443-448.
75. Lundberg J.M., Saria A. Vagal substance P nerves involved in control of vascular permeability and smooth muscle tone in trachea and bronchi. Br. J. Pharmacol. 77:1982;441P.
76. Lehr C.-M., Poelma F.G.J., Junginger H.E., Tukker J.J. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70:1991;235-240.
77. Glass G.B.J., Slomiany G.L. Derangements of biosynthesis, production and secretion of mucus in gastrointestinal injury and disease. Elstein M., Parke D.V., Mucus in Health and Disease. 1977;311-347 Plenum Press, New York.
78. Fraser G.M., Clamp J.R. Proceedings: changes in human colonic mucus in ulcerative colitis. Gut. 16:1975;832-833.
79. Goodman M.J., Kent P.W., Truelove S.C. Proceedings: glucosamine synthetase activity in the colonic mucosa in ulcerative colitis and Crohn's disease. Gut. 16:1975;833.
80. Bhat P.G., Flanagan D.R., Donovan M.D. Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology. J. Pharm. Sci. 85:1996;624-630.
81. Kim Y.S. Glycoprotein alteration in human colonic adenocarcinoma. Elstein M., Parke D.V., Mucus in Health and Disease I. 1977;443-468 Plenum Press, New York.
82. Filipe M.I. Value of histochemical reaction from mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum. Gut. 10:1969;577-586.
83. Filipe M.I., Branfoot A.C. Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer. 3492:1974;282-290.
84. Insler V. The evaluation and treatment of cervical mucus diseases leading to infertility. Elstein M., Parke D.V., Mucus in Health and Disease I. 1977;477-488 Plenum Press, New York.
85. Khan M.A., Wolf D.P., Litt M. Effect of mucolytic agents on the rheological properties of tracheal mucus. Biochim. Biophys. Acta. 444:1976;369-373.
86. Martin G.P., Newbery R.S., Turner N.C., Marriott C. Gastric mucosal injury by bile acids: the influence of phospholipids. Gastroenterol. Clin. Biol. 9:1985;80-83.
87. Currie D.C., Greenstone M., Pavia D., Agnew J.E., Pellow P., Clarke S.W., Hendry W.F., Cole P.J. Efficacy of `mucoregulatory' agents in Young's syndrome. Thorax. 43:1988;480-481.
88. Winne D., Verheyen W. Diffusion coefficient in native mucus gel of rat small intestine. J. Pharm. Pharmacol. 42:1990;517-519.
89. Grubel P., Cave D.R. Factors affecting solubility and penetration of clarithromycin through gastric mucus. Aliment. Pharmacol. Ther. 12:1998;569-576.
90. Bhat P.G., Flanagan D.R., Donovan M.D. The limiting role of mucus in drug absorption: drug permeation through mucus solution. Int. J. Pharmaceutics. 126:1995;179-187.
91. Bhaskar K.R., Garid P., Turner B.S., Bradley J.D., Bansil R., Stanley H.E., Lamont J.T. Viscous fingering of HCl through gastric mucin. Nature. 360:1992;458-461.
92. Desai M.A., Mutlu M., Vadgama P. A study of macromolecular diffusion through native porcine mucus. Experientia. 48:1992;22-26.
93. Matthes I., Nimmerfall F., Sucker H. Mucus models for investigation of intestinal absorption mechanisms. 1 Validation and optimization of the model. Pharmazie. 47:1992;505-515.
94. Flynn G.L., Yalkowsky S.H., Roseman T.J. Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci. 63:1974;479-510.
95. Westrin B.A., Axelsson A., Zacchi G. Diffusion measurement in gels. J. Controlled Release. 30:1994;189-199.
96. Owen D.H., Dunmire E.N., Plenys A.M., Katz D.F. Factors influencing nonoxynol-9 permeation and bioactivity in cervical mucus. J. Controlled Release. 60:1999;23-34.
97. Larhed A.W., Artursson P., Grasjo J., Bjork E. Diffusion of drugs in native and purified gastrointestinal mucus. J. Pharm. Sci. 86:1997;660-665.
98. Saltzman W.M., Radomsky M.L., Whaley K.J., Cone R.A. Antibody diffusion in human cervical mucus. Biophys. J. 66:1994;508-515.
99. Meyvis T.K.L., DeSmedt S.C., VanOostveldt P., Demeester J. Fluorescence recovery after photobleaching: a versatile tool for mobility and interaction measurements in pharmaceutical research. Pharm. Res. 16:1999;1153-1162.
100. Desai M.A., Nicholas C.V., Vadgama P. Electrochemical determination of the permeability of porcine mucus to model solute compounds. J. Pharm. Pharmacol. 43:1991;124-127.
101. Karlsson J., Wikman A., Artursson P. The mucus layer as a barrier to drug absorption in monolayers of human intestinal epithelial HT29-H goblet cells. Int. J. Pharmaceutics. 99:1993;209-218.
102. Wikman A., Karlsson J., Carlstedt I., Artursson P. A drug absorption model based on the mucus layer producing human intestinal goblet cell line HT29-H. Pharm. Res. 10:1993;843-852.
103. Allen J.D., Martin G.P., Marriott C., Hassan I., Williamson I. Drug transport across a novel mucin secreting cell model: comparison with the Caco-2 cell system. J. Pharm. Pharmacol. 43:1991;63P.
104. Niibuchi J.-J., Aramaki Y., Tsuchiya S. Binding of antibiotics to rat intestinal mucin. Int. J. Pharmaceutics. 30:1986;181-187.
105. Barry B.W., Braybrooks M.P. Influence of a mucin model system upon the bioavailability of phenylbutazone and warfarin sodium from the small intestine. J. Pharm. Pharmacol. 26:1975;74P.
106. Braybrooks M.P., Barry B.W., Abbs E.T. The effect of mucin on the bioavailability of tetracycline from the gastrointestinal tract: in vivo, in vitro correlations. J. Pharm. Pharmacol. 27:1975;508-515.
107. Kearney P., Marriott C. The effects of mucus glycoproteins on the bioavailability of tetracycline. 2. Binding. Int. J. Pharmaceutics. 35:1987;211-220.
108. Stephen K.L. Mucus on the epidermis of fish and its influence on drug delivery. Adv. Drug Del. Rev. 11:1993;403-417.
109. Sanders N.N., DeSmedt S.C., Demeester J. The physical properties of biogels and their permeability for macromolecular drugs and colloidal drug carriers. J. Pharm. Sci. 89:2000;835-849.
110. Ron N., Theis C. Nanoparticle transport in gels including mucus. Proc. Intl. Symp. Control. Rel. Bioact. Mater. 25:1998;376-377.
111. Szentkuti L. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. J. Controlled Release. 46:1997;233-242.
112. Norris D.A., Sinko P.J. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J. Appl. Polymer Sci. 63:1997;1481-1492.
113. Bataillon V., Lhermitte M., Lafitte J.J., Pommery J., Roussel P. The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases. J. Antimicrob. Chemother. 29:1992;499-508.
114. Bolister N., Basker M., Hodges N.A., Marriott C. The diffusion of beta-lactam antibiotics through mixed gels of cystic fibrosis-derived mucin and Pseudomonas aeruginosa alginate. J. Antimicrob. Chemother. 27:1991;285-293.
115. Komiya I., Park J.Y., Kamani A., Ho N.F.H., Higuchi W.I. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as nodel solutes. Int. J. Pharmaceutics. 4:1980;249-262.
116. Franz J.M., Vonderscher J.P., Voges R. Contribution to the intestinal absorption of ergot peptide alkaloids. Int. J. Pharmaceutics. 7:1980;19-28.
117. Matthes I., Nimmerfall F., Sucker H. Mucus models for investigation of intestinal absorption mechanisms. 2. Mechanisms of drug interactions with intestinal mucus. Pharmazie. 47:1992;609-613.
118. MacAdam A. The effect of gastro-intestinal mucus on drug absorption. Adv. Drug Del. Rev. 11:1993;201-220.
119. Meyer M.C., Guttman D.E. The binding of drugs by plasma proteins. J. Pharm. Sci. 57:1968;895-918.
120. C.F. Chignell, Protein binding, in: E.R. Garrett, J.L. Hirtz (Eds.), Drug Fate and Metabolism: Methods, and Techniques, Vol. 1, Marcel Dekker, New York, 1977, pp. 187-228.
121. Kurz H., Trunk N., Weitz B. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration. Arzneim.-Forsch. 27:1977;1373-1380.
122. Vallner J.J. Binding of drugs by albumin and plasma protein. J. Pharm. Sci. 66:1977;447-465.
123. Nakano N.I., Oshio T., Sato N., Shimamori Y., Yamaguchi S. Studies of drug-protein binding by affinity chromatography: interactions of bovine serum albumin and various ligands. Chem. Pharm. Bull. 27:1979;2048-2055.
124. Klotz I.M. Physicochemical aspects of drug-protein interactions: a general perspective. Ann. N.Y. Acad. Sci. 226:1973;18-35.
125. Bhat P.G., Flanagan D.R., Donovan M.D. Drug binding to gastric mucus glycoproteins. Int. J. Pharm. 134:1996;15-25.
126. Peppas N.A., Hansen P.J., Buri P.A. A theory of molecular diffusion in the intestinal mucus. Int. J. Pharm. 20:1984;107-118.
127. Fahr A., Guitard P., Matthes I., Nimmerfall F., Nuesch E., Sucker H. Mucus models for investigation of intestinal absorption. Part 3: A mathematical simulation model of drug diffusion through the centeral mucus. Pharmazie. 47:1992;699-704.
128. Henry B.T., Adler J., Hibberd S., Cheema M.S., Davis S.S., Rogers T.G. Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems. J. Pharm. Pharmacol. 44:1992;543-549.
129. Crank J.S. Mathematics of Diffusion. 2nd Edition :1975;44-68 Oxford University Press, Brendon.